Primary aldosteronism, also referred to as Conn syndrome or hyperaldosteronism, was initially identified in 1955 by Jerome W. Conn, an American endocrinologist. Conn’s discovery occurred when he evaluated a patient with hypertension caused by the presence of an adrenal gland tumor. Since then, researchers have made significant advancements in understanding this rare condition. Although its occurrence is relatively low, affecting between 0.1 and 20 percent of specific populations, primary aldosteronism plays a crucial role in the development of various chronic conditions.
Understanding Aldosterone and Its Role in Blood Pressure Regulation
Aldosterone is a vital hormone that plays a crucial role in the body’s ability to regulate blood pressure effectively. This hormone is produced in the adrenal glands and is responsible for controlling the levels of sodium and potassium in the bloodstream and urine. By signaling the appropriate amount of these essential minerals to be released, aldosterone helps maintain the delicate balance necessary for maintaining optimal serum pH and electrolyte levels, which directly impact cardiovascular function.
Adrenal Adenoma: A Common Cause of “Primary” Aldosteronism
Adrenal adenoma, a benign tumor that develops in the glomerulosa cells of the adrenal cortex, is responsible for the majority of cases of “primary” aldosteronism. This condition primarily affects the adrenal glands and is more prevalent in males aged between 30 and 50. However, it is important to note that in less than one percent of cases, the tumor may be a carcinoma, requiring a different approach in terms of medical treatment.